1. 1048OM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients (pts) with advanced SCCHN: Results from a phase I cohort. (23rd October 2018) Authors: Cho, B C; Daste, A; Ravaud, A; Salas, S; Isambert, N; McClay, E; Awada, A; Borel, C; Gulley, J; Ojalvo, L; Helwig, C; Rolfe, P A; Penel, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 153OM7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype. (25th November 2018) Authors: Yoo, C; Oh, D-Y; Choi, H J; Kudo, M; Ueno, M; Kondo, S; Chen, L-T; Osada, M; Helwig, C; Dussault, I; Ikeda, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 643PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with post-platinum esophageal adenocarcinoma (EAC): Preliminary results from a phase I cohort. (23rd October 2018) Authors: Tan, B; Khattak, A; Felip, E; Kelly, K; Rich, P; Wang, D; Helwig, C; Dussault, I; Ojalvo, L; Isambert, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 661PUpdated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer. (23rd October 2018) Authors: Bang, Y-J; Doi, T; Kondo, S; Chung, H C; Muro, K; Dussault, I; Helwig, C; Osada, M; Kang, Y-K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 757PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial. (23rd October 2018) Authors: Yoo, C; Oh, D-Y; Choi, H J; Kudo, M; Ueno, M; Kondo, S; Chen, L-T; Osada, M; Helwig, C; Dussault, I; Ikeda, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P37 Phase 1 evaluation of bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer. (1st November 2019) Authors: Allan, S; Braiteh, F; Calvo Aller, E; Cervantes, A; Edenfield, W; Li, T; Rasschaert, M; Park-Simon, T-W; Longo, F; Paz-Ares, L; Spira, A; Strauss, J; Ojalvo, LS; Helwig, C; Dussault, I; Gulley, JL Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗